A Translational Determination of the Mechanisms of Maladaptive Choice in Opioid Use Disorder

阿片类药物使用障碍适应不良选择机制的转化测定

基本信息

  • 批准号:
    10357944
  • 负责人:
  • 金额:
    $ 62.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-15 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

ABSTRACT Opioid use disorder (OUD) is characterized by the decision to use opioids at the expense of other activities. Lab-based efforts to address this problem have therefore included opioid choice self-administration procedures that incorporate a non-drug alternative to model this defining feature. Studies using these procedures have typically scheduled competing reinforcers so that the probabilities are certain. However, such deterministic outcomes are not representative of real-world experiences in which the consequences from drug-related choices are often unpredictable. Importantly, decision-making in a dynamic, uncertain context significantly alters the value of choice options and requires continuous updating of option values, which engages learning processes and related corticostriatal networks that function abnormally in OUD. Decision-making in dynamic environments has been successfully modeled using probabilistic reinforcement-learning choice (PRLC) tasks. The integration of these tasks with reinforcement-learning (RL) computational modeling has been used to capture moment-to- moment changes in the mechanisms of dynamic choice, and the application of neuroscience techniques has begun to identify the underlying neurobiology. This approach has uncovered biologically-based decision-making abnormalities in multiple brain disorders, but has yet to be systematically applied to the experimental study of OUD, The translation of combined RL and neuroscience approaches to OUD is logical considering the maladaptive choice behavior that typifies the disorder, the varying reinforcement probabilities in opioid users’ natural environments, and the learning impairments that have been documented in individuals with OUD. Thus, there are critical gaps in our understanding of the mechanisms underlying dynamic opioid use decisions, and a strong scientific premise for applying an RL framework to fill these gaps. This project proposes rigorous PRLC tasks, RL modeling, neurorecording/fMRI neuroimaging techniques and complementary, translational study designs in rats and humans. The first set of cross-species experiments will demonstrate the impact of opioid exposure and withdrawal on dynamic decision-making and reveal the neurobehavioral and neurobiological processes underlying abnormal task performance. The second set of experiments will use a PRLC task in which intravenous remifentanil, a prototypical opioid agonist with a favorable safety profile, is available as an alternative to a non-drug reinforcer to determine the behavioral and neural “profiles” associated with drug choice, as well as the increases and decreases in drug choice that occur during withdrawal and in the presence of a large magnitude alternative reinforcer, respectively. This project will have a significant impact on the field by establishing the experimental application of reinforcement-learning theory to the study of maladaptive dynamic drug-use decision-making in OUD to reveal behavioral and neural mechanisms that can be targeted for future prevention and treatment development.
抽象的 阿片类药物使用障碍(OUD)的特征是决定使用阿片类药物以其他活动为代价。 因此,基于实验室解决此问题的努力包括阿片类药物选择自我管理程序 这结合了建模此定义特征的非药水替代方案。使用这些程序的研究 通常是安排的竞争增强剂,以确定可能性。但是,这样的确定性 结果并不代表现实世界的经验,在这种经验中,与药物相关选择的后果 通常是不可预测的。重要的是,在动态,不确定的环境中的决策显着改变了 选择选项的价值,并且需要连续更新选项值,以吸引学习过程 和相关的皮质纹状体网络,在OUD中起作用。动态环境中的决策 已通过概率增强学习选择(PRLC)任务成功建模。整合 在使用加强学习(RL)计算建模的这些任务中 动态选择机制的力矩变化,神经科学技术的应用具有 开始识别潜在的神经生物学。这种方法发现了基于生物学的决策 多种脑部疾病异常,但尚未系统地应用于 oud,考虑到的RL和神经科学方法的翻译是合乎逻辑的 适应不良的选择行为,代表该疾病,阿片类药物使用者的强化可能性不同 自然环境以及OUD个人记录的学习障碍。那, 我们对动态阿片类药物使用决策的机制的理解存在关键的差距,并且 强烈的科学信念应用RL框架来填补这些空白。这个项目提议严格的PRLC 任务,RL建模,神经记录/FMRI神经影像学技术和完整的翻译研究 在老鼠和人类中设计。第一组跨物种实验将证明Opoid的影响 在动态决策中暴露和退出,并揭示神经行为和神经生物学 任务绩效异常的过程。第二组实验将使用PRLC任务 静脉注射雷曲霉,一种具有良好安全性的原型阿片类动力学家,可作为替代品可用 到非药物增强剂来确定与药物选择相关的行为和神经“特征”,以及 戒断期间发生的药物选择的增加和减少 大小替代增强器。该项目将对该领域产生重大影响 建立强化学习理论在不良适应动态的研究中的实验应用 OUD中的药物使用决策,以揭示可以针对未来的行为和神经机制 预防和治疗发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Joshua Beckmann的其他基金

A Translational Determination of the Mechanisms of Maladaptive Choice in Opioid Use Disorder
阿片类药物使用障碍适应不良选择机制的转化测定
  • 批准号:
    9913503
    9913503
  • 财政年份:
    2019
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:
A Translational Determination of the Mechanisms of Maladaptive Choice in Opioid Use Disorder
阿片类药物使用障碍适应不良选择机制的转化测定
  • 批准号:
    10565857
    10565857
  • 财政年份:
    2019
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:
A translational determination of the mechanisms of maladaptive choice in cocaine use disorder
可卡因使用障碍适应不良选择机制的转化测定
  • 批准号:
    10398833
    10398833
  • 财政年份:
    2018
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:
A translational determination of the mechanisms of maladaptive choice in cocaine use disorder
可卡因使用障碍适应不良选择机制的转化测定
  • 批准号:
    9922897
    9922897
  • 财政年份:
    2018
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:
Tonic and Phasic Glutamate Release in Incentive Salience and Cocaine Reinforcemen
激励显着性和可卡因强化剂中的补品和阶段性谷氨酸释放
  • 批准号:
    8898930
    8898930
  • 财政年份:
    2014
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:
Tonic and Phasic Glutamate Release in Incentive Salience and Cocaine Reinforcemen
激励显着性和可卡因强化剂中的补品和阶段性谷氨酸释放
  • 批准号:
    9131675
    9131675
  • 财政年份:
    2014
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:
Tonic and Phasic Glutamate Release in Incentive Salience and Cocaine Reinforcemen
激励显着性和可卡因强化剂中的补品和阶段性谷氨酸释放
  • 批准号:
    8457019
    8457019
  • 财政年份:
    2012
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:
Tonic and Phasic Glutamate Release in Incentive Salience and Cocaine Reinforcemen
激励显着性和可卡因强化剂中的补品和阶段性谷氨酸释放
  • 批准号:
    8281092
    8281092
  • 财政年份:
    2012
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:

相似国自然基金

趋化因子CXCL14在胚胎植入中的作用及机制研究
  • 批准号:
    30670785
  • 批准年份:
    2006
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目
人工泵式括约肌对去肛门括约肌犬节制排便的实验研究
  • 批准号:
    39670706
  • 批准年份:
    1996
  • 资助金额:
    8.0 万元
  • 项目类别:
    面上项目

相似海外基金

A Translational Determination of the Mechanisms of Maladaptive Choice in Opioid Use Disorder
阿片类药物使用障碍适应不良选择机制的转化测定
  • 批准号:
    9913503
    9913503
  • 财政年份:
    2019
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:
A Translational Determination of the Mechanisms of Maladaptive Choice in Opioid Use Disorder
阿片类药物使用障碍适应不良选择机制的转化测定
  • 批准号:
    10565857
    10565857
  • 财政年份:
    2019
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:
Intervention for Teens with ADHD and Substance Use
对患有多动症和药物滥用的青少年进行干预
  • 批准号:
    8631364
    8631364
  • 财政年份:
    2014
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:
The Efficacy of CBT-I in Alcoholics & Its Effects on Remission & Relapse
CBT-I 对酗酒者的功效
  • 批准号:
    8634474
    8634474
  • 财政年份:
    2014
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别:
The Efficacy of CBT-I in Alcoholics & Its Effects on Remission & Relapse
CBT-I 对酗酒者的功效
  • 批准号:
    8811012
    8811012
  • 财政年份:
    2014
  • 资助金额:
    $ 62.51万
    $ 62.51万
  • 项目类别: